HBA’s Annual Conference was held in Washington, D.C. on November 5-6, with over 900 attendees-both men and women.
HBA’s ACE Awards kicked-off the conference activities with a luncheon event that honored the 2018 recipients-Pfizer, Insigniam, and KMPG for their women’s leadership initiatives. An ACE Awards retrospective also recognized the previous 12 recipients in appreciation for integrating women’s leadership programs into their organizational DNA.
Willard McCloud, global lead, diversity & inclusion and culture, Pfizer and Sabina Ewing, vice president, business technology, global women’s council chair, Pfizer
Jon Kleinman, partner, and Shideh Bina, founding partner
Topics at the conference ranged from “How Artificial Intelligence and Machine Learning are Transforming Healthcare” to “Find Your Mojo and Leverage Your Superpowers.” Lisa Henderson, Pharm Exec’s editorial director, spoke about Pharm Exec’s coverage and support of female industry leaders. Attendees also heard from mindfulness expert Susan O’Connor, a former executive at Pfizer, who shared her approach on how to balance personal well-being with the demands of work life. Lisa Bodell, founder, future think, closed out the conference sharing best practices on how to eliminate complexity from the daily grind.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.